A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Clinical trial NCT03832946 · COMPLETED
Trial details
- NCT number
- NCT03832946
- Sponsor
- Galecto Biotech AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-19
- Primary completion
- 2023-05-17
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.